ANTI-TRANSTHYRETIN ANTIBODIES
The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for dia...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SALMANS, Joshua Reginald BARBOUR, Robin ALEXANDER, Svetlana HIGAKI, Jeffrey N NIJJAR, Tarlochan S |
| description | The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, and for monitoring the efficacy of TTR therapies, among other applications. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020331992A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020331992A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020331992A13</originalsourceid><addsrcrecordid>eNrjZJB19Avx1A0JcvQLDvGIDHIN8fRTAAk5-bt4ugbzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjAyMDY2NDS0sjR0Nj4lQBADiPIlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-TRANSTHYRETIN ANTIBODIES</title><source>esp@cenet</source><creator>SALMANS, Joshua Reginald ; BARBOUR, Robin ; ALEXANDER, Svetlana ; HIGAKI, Jeffrey N ; NIJJAR, Tarlochan S</creator><creatorcontrib>SALMANS, Joshua Reginald ; BARBOUR, Robin ; ALEXANDER, Svetlana ; HIGAKI, Jeffrey N ; NIJJAR, Tarlochan S</creatorcontrib><description>The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, and for monitoring the efficacy of TTR therapies, among other applications.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201022&DB=EPODOC&CC=US&NR=2020331992A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201022&DB=EPODOC&CC=US&NR=2020331992A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SALMANS, Joshua Reginald</creatorcontrib><creatorcontrib>BARBOUR, Robin</creatorcontrib><creatorcontrib>ALEXANDER, Svetlana</creatorcontrib><creatorcontrib>HIGAKI, Jeffrey N</creatorcontrib><creatorcontrib>NIJJAR, Tarlochan S</creatorcontrib><title>ANTI-TRANSTHYRETIN ANTIBODIES</title><description>The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, and for monitoring the efficacy of TTR therapies, among other applications.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB19Avx1A0JcvQLDvGIDHIN8fRTAAk5-bt4ugbzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjAyMDY2NDS0sjR0Nj4lQBADiPIlA</recordid><startdate>20201022</startdate><enddate>20201022</enddate><creator>SALMANS, Joshua Reginald</creator><creator>BARBOUR, Robin</creator><creator>ALEXANDER, Svetlana</creator><creator>HIGAKI, Jeffrey N</creator><creator>NIJJAR, Tarlochan S</creator><scope>EVB</scope></search><sort><creationdate>20201022</creationdate><title>ANTI-TRANSTHYRETIN ANTIBODIES</title><author>SALMANS, Joshua Reginald ; BARBOUR, Robin ; ALEXANDER, Svetlana ; HIGAKI, Jeffrey N ; NIJJAR, Tarlochan S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020331992A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SALMANS, Joshua Reginald</creatorcontrib><creatorcontrib>BARBOUR, Robin</creatorcontrib><creatorcontrib>ALEXANDER, Svetlana</creatorcontrib><creatorcontrib>HIGAKI, Jeffrey N</creatorcontrib><creatorcontrib>NIJJAR, Tarlochan S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SALMANS, Joshua Reginald</au><au>BARBOUR, Robin</au><au>ALEXANDER, Svetlana</au><au>HIGAKI, Jeffrey N</au><au>NIJJAR, Tarlochan S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-TRANSTHYRETIN ANTIBODIES</title><date>2020-10-22</date><risdate>2020</risdate><abstract>The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, and for monitoring the efficacy of TTR therapies, among other applications.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2020331992A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | ANTI-TRANSTHYRETIN ANTIBODIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T20%3A37%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SALMANS,%20Joshua%20Reginald&rft.date=2020-10-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020331992A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |